Perspectives of targeting mTORC1-S6K1 in cardiovascular aging

Frontiers in Physiology

Volumn 3 JAN, Issue , 2012, Pages

  Ming, Xiu Fen ^a   Montani, Jean Pierre ^a   Yang, Zhihong ^a  

^a University of Fribourg   (Switzerland)

Author keywords

Aging; Endothelial senescence; eNOS; mTOR; Oxidative stress; Rapamycin; Resveratrol; S6K1

Indexed keywords

EID: 84864833164     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00005     Document Type: Article

References (145)

1. Adelman, S. J. (2010). Sirolimus and its analogs and its effects on vascular diseases. Curr. Pharm. Des. 16, 4002-4011.
2. Antoniades, C., Shirodaria, C., Leeson, P., Antonopoulos, A., Warrick, N., VanAssche, T., Cunnington, C., Tousoulis, D., Pillai, R., Ratnatunga, C., Stefanadis, C., and Channon, K. M. (2009). Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur. Heart J. 30, 1142-1150.
3. Barger, J. L., Kayo, T., Vann, J. M., Arias, E. B., Wang, J., Hacker, T. A., Wang, Y., Raederstorff, D., Morrow, J. D., Leeuwenburgh, C., Allison, D. B., Saupe, K. W., Cartee, G. D., Weindruch, R., and Prolla, T. A. (2008). A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS ONE 3, e2264. doi:10.1371/journal.pone.0002264
4. Basso, M. D., Nambi, P., and Adelman, S. J. (2003). Effect of sirolimus on the cholesterol content of aortic arch in ApoE knockout mice. Transplant. Proc. 35,3136-3138.
5. Baur, J. A. (2010). Resveratrol, sirtuins, and the promise of a DR mimetic. Mech. Ageing Dev. 131,261-269.
6. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., LopezLluch, G., Lewis, K., Pistell, P. J., Poosala, S., Becker, K. G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K. W., Spencer, R. G., Lakatta, E. G., Le, C. D., Shaw, R. J., Navas, P., Puigserver, P., Ingram, D. K., de, C. R., and Sinclair, D. A. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342.
7. Bendall, J. K., Alp, N. J., Warrick, N., Cai, S., Adlam, D., Rockett, K., Yokoyama, M., Kawashima, S., and Channon, K. M. (2005). Stoichiometric relationships between endothelial tetrahy-drobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression. Circ. Res. 97, 864-871.
8. Berkowitz, D. E., White, R., Li, D., Min-has, K. M., Cernetich, A., Kim, S., Burke, S., Shoukas, A. A., Nyhan, D., Champion, H. C., and Hare, J. M. (2003). Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108, 2000-2006.
9. Blagosklonny, M. V. (2008). Aging: ROS or TOR. Cell Cycle 7, 3344-3354.
10. Boluyt, M. O., Zheng, J. S., Younes, A., Long, X., O'Neill, L., Silverman, H., Lakatta, E. G., and Crow, M. T. (1997). Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase. Circ. Res. 81, 176-186.
11. Brandes, R. P., Fleming, I., and Busse, R. (2005). Endothelial aging. Cardio-vasc. Res. 66, 286-294.
12. Bugiardini, R., Manfrini, O., Pizzi, C., Fontana, F., and Morgagni, G. (2004). Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 109,2518-2523.
13. Camici, G. G., Steffel, J., Amanovic, I., Breitenstein, A., Baldinger, J., Keller, S., Luscher, T. F., and Tanner, F. C. (2010). Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus elut-ing stents. Eur. Heart J. 31, 236-242.
14. Campistol, J. M., Eris, J., Oberbauer, R., Friend, P., Hutchison, B., Morales, J. M., Claesson, K., Stallone, G., Russ, G., Rostaing, L., Kreis, H., Burke, J. T., Brault, Y., Scarola, J. A., and Neylan, J. F. (2006). Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J. Am. Soc.Nephrol. 17,581-589.
15. Canto, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., and Auwerx, J. (2009). AMPK regulates energy expenditure by modulating NAD+ metabolism andSIRT1 activity. Nature 458, 1056-1060.
16. Cao, K., Graziotto, J. J., Blair, C. D., Mazzulli, J. R., Erdos, M. R., Krainc, D., and Collins, F. S. (2011). Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in hutchinson-gilford progeria syndrome cells. Sci. Transl. Med. 3, 89ra58.
17. Chan, A. Y., Dolinsky, V. W., Soltys, C. L., Viollet, B., Baksh, S., Light, P. E., and Dyck, J. R. (2008). Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J. Biol. Chem. 283, 24194-24201.
18. Chang, G. R., Wu, Y. Y., Chiu, Y S., Chen, W. Y., Liao, J. W., Hsu, H. M., Chao, T. H., Hung, S. W., and Mao, F. C. (2009). Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK/HlJ mice. Basic Clin. Pharmacol. Toxicol. 105, 188-198.
19. Chen, C., Liu, Y., Liu, Y., and Zheng, P. (2009). mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci. Signal. 2, ra75.
20. Chen, C. A., Wang, T. Y., Varadharaj, S., Reyes, L. A., Hemann, C., Talukder, M. A., Chen, Y R., Druhan, L. J., and Zweier, J. L. (2010). S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 468, 1115-1118.
21. Christensen, K., Doblhammer, G., Rau, R., and Vaupel, J. W. (2009). Ageing populations: the challenges ahead. Lancet 374, 1196-1208.
22. Christensen, K., McGue, M., Petersen, I., Jeune, B., and Vaupel, J. W. (2008). Exceptional longevity does not result in excessive levels of disability. Proc. Natl. Acad. Sci. U.S.A. 105,13274-13279.
23. Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de, C. R., and Sinclair, D. A. (2004). Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390-392.
24. Colman, R. J., Anderson, R. M.,Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., and Weindruch, R. (2009). Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325,201-204.
25. Csiszar, A., Smith, K., Labinskyy, N., Orosz, Z., Rivera, A., and Ungvari, Z. (2006). Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition. Am. J. Phys-iol. Heart Circ. Physiol. 291, H1694-H1699.
26. Csiszar, A., Ungvari, Z., Edwards, J. G., Kaminski, P., Wolin, M. S., Koller, A., and Kaley, G. (2002). Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ. Res. 90,1159-1166.
27. Csiszar, A., Ungvari, Z., Koller, A., Edwards, J. G., and Kaley, G. (2004). Proinflammatory pheno-type of coronary arteries promotes endothelial apoptosis in aging. Physiol. Genomics 17,21-30.
28. Csiszar, A., Wang, M., Lakatta, E. G., and Ungvari, Z. (2008). Inflammation and endothelial dysfunction during aging: role of NF-kappaB. J. Appl. Physiol. 105,1333-1341.
29. Cunningham, J. T., Ro dgers, J. T., Arlow, D. H., Vazquez, F., Mootha, V K., and Puigserver, P. (2007a). mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450, 736-740.
30. Cunningham, J. T., Rodgers, J. T., Arlow, D. H., Vazquez, F., Mootha, V K., and Puigserver, P. (2007b). mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450, 736-740.
31. Dann, S. G., Selvaraj, A., and Thomas, G. (2007). mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol. Med. 13,252-259.
32. Desrois, M., Clarke, K., Lan, C., Dalmasso, C., Cole, M., Portha, B., Cozzone, P. J., and Bernard, M. (2010). Upregulation of eNOS and unchanged energy metabolism in increased susceptibility of the aging type 2 diabetic GK rat heart to ischemic injury. Am. J. Physiol. Heart Circ. Physiol. 299, H1679-H1686.
33. Drummond, G. R., Cai, H., Davis, M. E., Ramasamy S., and Harrison, D. G. (2000). Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ. Res. 86, 347-354.
34. Elloso, M. M., Azrolan, N., Sehgal, S. N., Hsu, P. L., Phiel, K. L., Kopec, C. A., Basso, M. D., and Adelman, S. J. (2003). Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice. Am. J. Transplant. 3, 562-569.
35. Estep, P. W III, Warner, J. B., and Bulyk, M. L. (2009). Short-term calorie restriction in male mice feminizes gene expression and alters key regulators of conserved aging regulatory pathways. PLoS ONE 4, e5242. doi:10.1371/journal.pone.0005242
36. Evans, D. S., Kapahi, P., Hsueh, W .C., and Kockel, L. (2011). TOR signaling never gets old: aging, longevity and TORC1 activity. Ageing Res. Rev. 10,225-237.
37. Fontana, L., Meyer, T. E., Klein, S., and Holloszy, J. O. (2004). Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc. Natl. Acad. Sci. U.S.A. 101,6659-6663.
38. Fontana, L., Partridge, L., and Longo, V D. (2010). Extending healthy life span - from yeast to humans. Science 328,321-326.
39. Forstermann, U., and Munzel, T. (2006). Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113,1708-1714.
40. Foster, K. G., and Finger, D. C. (2010). Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J. Biol. Chem. 285, 14071-14077.
41. Frost, R. A., and Lang, C. H. (2011). mTor signaling in skeletal mus]cle during sepsis and inflammation: where does it all go wrong? Physiol]ogy (Bethesda) 26, 83-96.
42. Glazer, H. P., Osipov, R. M., Clements, R. T., Sellke, F. W., and Bianchi, C. (2009). Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling. Cell Cycle 8, 1738-1746.
43. Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Kletsas, D., Mariatos, G., Zoumpourlis, V., Ryan, K. M., Kittas, C., and Papavassiliou, A. G. (2003). p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner. EMBOJ. 22, 1567-1578.
44. Halcox, J. P., Schenke, W. H., Zalos, G., Mincemoyer, R., Prasad, A., Waclawiw, M. A., Nour, K. R., and Quyyumi, A. A. (2002). Prognostic value of coronary vascular endothelial dysfunction. Circulation 106, 653-658.
45. Hammer, S., Snel, M., Lamb, H. J., Jazet, I. M., van der Meer, R. W., Pijl, H., Meinders, E. A., Romijn, J. A., de, R. A., and Smit, J. W. (2008). Prolonged caloric restriction in obese patients with type 2 diabetes mel-litus decreases myocardial triglyc-eride content and improves myocardial function. J.Am. Coll. Cardiol. 52, 1006-1012.
46. Hands, S. L., Proud, C. G., and Wytten-bach, A. (2009). mTOR's role in ageing: protein synthesis or autophagy? Aging (Albany NY) 1, 586-597.
47. Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., Pahor, M., Javors, M. A., Fernandez, E., and Miller, R. A. (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392-395.
48. Hatakeyama, K., Asada, Y., Marutsuka, K., Sato, Y., Kamikubo, Y., and Sumiyoshi, A. (1997). Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis 133,213-219.
49. Herranz, D., and Serrano, M. (2010). SIRT1: recent lessons from mouse models. Nat. Rev. Cancer 10, 819-823.
50. Herrera, M. D., Mingorance, C., Rodriguez-Rodriguez, R., and Alvarez de,S.M. (2010). Endothelial dysfunction and aging: an update. Ageing Res. Rev. 9, 142-152.
51. Hill, J. M., Zalos, G., Halcox, J. P., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., and Finkel, T. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl. J. Med. 348, 593-600.
52. Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R. A., Warnholtz, A., Meinertz, T., Griendling, K., Harrison, D. G., Forstermann, U., and Munzel, T. (2001). Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 88, E14-E22.
53. Hoffmann, J., Haendeler, J., Aicher, A., Rossig, L., Vasa, M., Zeiher, A. M., and Dimmeler, S. (2001). Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ. Res. 89, 709-715.
54. Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Geloen, A., Even, P. C., Cervera, P., and Le, B. Y. (2003). IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421, 182-187.
55. Huang, P. H., Chen, J. W., Lu, T. M., Yu-An, D. P., and Lin, S. J. (2007). Combined use of endothelial function assessed by brachial ultrasound and high-sensitive C-reactive protein in predicting cardiovascular events. Clin. Cardiol. 30,135-140.
56. Huang, P. H., Chen, Y H., Tsai, H. Y., Chen, J. S., Wu, T. C., Lin, F. Y., Sata, M., Chen, J. W., and Lin, S. J. (2010). Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler. Thromb. Vasc. Biol. 30, 869-877.
57. Hudes, G., Carducci, M., Tomczak, P., Dutcher, J., Figlin, R., Kapoor, A., Staroslawska, E., Sosman, J., McDermott, D., Bodrogi, I., Kovacevic, Z., Lesovoy,V., Schmidt-Wolf, I. G.,Barbarash, O., Gokmen, E., O'Toole, T., Lustgarten, S., Moore, L., and Motzer, R. J. (2007). Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl. J. Med. 356,2271-2281.
58. Inoue, T., Croce, K., Morooka, T., Sakuma, M., Node, K., and Simon, D. I. (2011). Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis. JACC Cardiovasc. Interv. 4,1057-1066.
59. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., and Pezzuto, J. M. (1997). Cancer chemopreven- tive activity of resveratrol, a natural product derived from grapes. Science 275,218-220.
60. Kaeberlein, M., and Kennedy, B. K. (2009). Ageing: a midlife longevity drug? Nature 460, 331-332.
61. Kagawa, Y. (1978). Impact of Westernization on the nutrition of Japanese: changes in physique, cancer, longevity and centenarians. Prev. Med. 7, 205-217.
62. Kapahi, P., and Zid, B. (2004). TOR pathway: linking nutrient sensing to life span. Sci. Aging Knowledge Environ. 2004, E34.
63. Kauffman, H. M., Cherikh, W S., Cheng, Y., Hanto, D. W., and Kahan, B. D. (2005). Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 80, 883-889.
64. Kim, J. A., Jang, H. J., Martinez-Lemus, L. A., and Sowers, J. R. (2012). Activation of mTOR/p70S6 kinase by ANG II inhibits insulin stimulated endothelial nitric oxide synthase and vasodilation. Am. J. Phys-iol. Endocrinol. Metab. 302, E201-E208.
65. Kitada, M., Kume, S., Imaizumi, N., and Koya, D. (2011). Resveratrol improves oxidative stress and protects against diabetic nephropa-thy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 60, 634-643.
66. Kurdi, M., and Booz, G. W. (2011). Three 4-letter words of hypertension-related cardiac hypertrophy: TRPC, mTOR, and HDAC. J. Mol. Cell. Cardiol. 50, 964-971.
67. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Geny, B., Laakso, M., Puigserver, P., and Auwerx, J. (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activat-ingSIRT1 andPGC-1alpha. Cell 127, 1109-1122.
68. Lakatta, E. G. (2001). Heart aging: a fly in the ointment? Circ. Res. 88, 984-986.
69. Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., and Harrison, D. G. (2003). Oxidation of tetrahy- drobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 111, 1201-1209.
70. Law, B. K. (2005). Rapamycin: an anti-cancer immunosuppressant? Crit. Rev. Oncol. Hematol. 56, 47-60.
71. Lee, J. H., Budanov, A. V., Park, E. J., Birse, R., Kim, T. E., Perkins, G. A., Ocorr, K., Ellisman, M. H., Bodmer, R., Bier, E., and Karin, M. (2010). Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science 327, 1223-1228.
72. Li, H. L., Yin, R., Chen, D., Liu, D., Wang, D., Yang, Q., and Dong, Y G. (2007). Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy. J. Cell. Biochem. 100, 1086-1099.
73. Linford, N. J., Beyer, R. P., Gollahon, K., Krajcik, R. A., Malloy, V. L., Demas, V., Burmer, G. C., and Rabinovitch, P. S. (2007). Transcriptional response to aging and caloric restriction in heart and adipose tissue. Aging Cell 6, 673-688.
74. Luscher, T. F., Steffel, J., Eberli, F. R., Joner, M., Nakazawa, G., Tanner, F. C., and Virmani, R. (2007). Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115, 1051-1058.
75. Lutz, W., Sanderson, W., and Scherbov, S. (2008). The coming acceleration of global population ageing. Nature 451,716-719.
76. McMullen, J. R., Sherwood, M. C., Tarnavski, O., Zhang, L., Dorfman, A. L., Shioi, T., and Izumo, S. (2004). Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 109, 3050-3055.
77. Meyer, T. E., Kovacs, S. J., Ehsani, A. A., Klein, S., Holloszy, J. O., and Fontana, L. (2006). Long-term caloric restriction ameliorates the decline in diastolic function in humans. J. Am. Coll. Cardiol. 47, 398-402.
78. Miller, R. A., Harrison, D. E., Astle, C. M., Baur, J. A., Boyd, A. R., de, C. R., Fernandez, E., Flurkey, K., Javors, M. A., Nelson, J. F., Orihuela, C. J., Pletcher, S., Sharp, Z. D., Sinclair, D., Starnes, J. W., Wilkinson, J. E., Nadon, N. L., and Strong, R. (2011). Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med. Sci. 66, 191-201.
79. Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., Bemis, J. E., Xie, R., Disch, J. S., Ng, P. Y., Nunes, J. J., Lynch, A. V., Yang, H., Galonek, H., Israelian, K., Choy, W., Iffland, A., Lavu, S., Medvedik, O., Sinclair, D. A., Olefsky, J. M., Jirousek, M. R., Elliott, P. J., and Westphal, C. H. (2007). Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712-716.
80. Ming, X. F., Barandier, C., Viswambharan, H., Kwak, B. R., Mach, F., Mazzolai, L., Hayoz, D., Ruffieux, J., Rusconi, S., Montani, J. P., and Yang, Z. (2004). Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation 110,3708-3714.
81. Ming, X. F., Rajapakse, A. G., Car-vas, J. M., Ruffieux, J., and Yang, Z. (2009). Inhibition of S6K1 accounts partially for the anti-inflammatory effects of the arginase inhibitor Lnorvaline. BMC Cardiovasc. Disord. 9,12. doi:10.1186/1471-2261-9-12
82. Ming, X. F., Rajapakse, A. G., Carvas, J. M., Ruffieux, J., and Yang, Z. (2010). Opposing and uncoupling effects of mTORandS6K1 in the regulation of endothelial tissue factor expression. FEBSLett. 584, 135-140.
83. Miyauchi, H., Minamino, T., Tateno, K., Kunieda, T., Toko, H., and Komuro, I. (2004). Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 23, 212-220.
84. Morrisett, J. D., Abdel-Fattah, G., Hoogeveen, R., Mitchell, E., Ballantyne, C. M., Pownall, H. J., Opekun, A. R., Jaffe, J. S., Oppermann, S., and Kahan, B. D. (2002). Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients. J. Lipid Res. 43, 1170-1180.
85. Moschella, P. C., Rao, V. U., McDermott, P. J., and Kuppuswamy, D. (2007). Regulation of mTOR and S6K1 activation by the nPKC iso-forms, PKCepsilon and PKCdelta, in adult cardiac muscle cells. J. Mol. Cell. Cardiol. 43, 754-766.
86. Muniyappa, R., Montagnani, M., Koh, K. K., and Quon, M. J. (2007). Cardiovascular actions of insulin. Endocr. Rev. 28, 463-491.
87. Najjar, S. S., Scuteri, A., and Lakatta, E. G. (2005). Arterial aging: is it an immutable cardiovascular risk factor? Hypertension 46,454-462.
88. Ota, H., Eto, M., Ako, J., Ogawa, S., Iijima, K., Akishita, M., and Ouchi, Y. (2009). Sirolimus and everolimus induce endothelial cellular senescence via sirtuin 1 down-regulation: therapeutic implication of cilostazol after drug-eluting stent implantation. J. Am. Coll. Cardiol. 53, 2298-2305.
89. Ozaki, M., Kawashima, S., Yamashita, T., Hirase, T., Namiki, M., Inoue, N., Hirata, K., Yasui, H., Sakurai, H., Yoshida, Y., Masada, M., and Yokoyama, M. (2002). Over-expression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J. Clin. Invest. 110, 331-340.
90. Pakala, R., Stabile, E., Jang, G. J., Clavijo, L., and Waksman, R. (2005). Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis. J. Cardiovasc. Pharmacol. 46,481-486.
91. Pan, K. Z., Palter, J. E., Rogers, A. N., Olsen, A., Chen, D., Lithgow, G. J., and Kapahi, P. (2007). Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell 6, 111-119.
92. Park, J. S., Kim, K. M., Kim, M. H., Chang, H. J., Baek, M. K., Kim, S. M., and Jung, Y. D. (2009). Resveratrol inhibits tumor cell adhesion to endothelial cells by blocking ICAM-1 expression. Anticancer Res. 29, 355-362.
93. Pearson, K. J., Baur, J. A., Lewis, K. N., Peshkin, L., Price, N. L., Labin-skyy, N., Swindell, W. R., Kamara, D., Minor, R. K., Perez, E., Jamieson, H. A., Zhang, Y., Dunn, S. R., Sharma, K., Pleshko, N., Woollett, L. A., Csiszar, A., Ikeno, Y., Le, C. D., Elliott, P. J., Becker, K. G., Navas, P., Ingram, D. K., Wolf, N. S., Ungvari, Z., Sinclair, D. A., and de, C. R. (2008). Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 8, 157-168.
94. Pirola, L., and Frojdo, S. (2008). Resveratrol: one molecule, many targets. IUBMB Life 60, 323-332.
95. Powers, R. W. III, Kaeberlein, M., Cald-well, S. D., Kennedy, B. K., and Fields, S. (2006). Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 20, 174-184.
96. Rajapakse, A. G., Ming, X. F., Carvas, J. M., and Yang, Z. (2009). The hex-osamine biosynthesis inhibitor aza-serine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects. Am. J. Physiol. Heart Circ. Physiol. 296, H815-H822.
97. Rajapakse, A. G., Yepuri, G., Carvas, J. M., Stein, S., Matter, C. M., Scerri, I., Ruffieux, J., Montani, J. P., Ming, X. F., and Yang, Z. (2011). Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol. PLoS ONE 6, e 19237. doi:10.1371/journal.pone.0019237
98. Rau, R., Soroko, E., Jasilionis, D., and Vaupel, J. W. (2008). Continued reductions in mortality at advanced ages. Popul. Dev. Rev. 34, 747-768.
99. Rauscher, F. M., Goldschmidt-Clermont, P. J., Davis, B. H., Wang, T., Gregg, D., Ramaswami, P., Pippen, A. M., Annex, B. H., Dong, C., and Taylor, D. A. (;2003). Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108, 457-463.
100. Reaven, G. M. (2011). Insulin resistance: the link between obesity and cardio vascular disease. Med. Clin. North Am. 95, 875-892.
101. Ribes, D., Kamar, N., Esposito, L., and Rostaing, L. (2005). Combined use of tacrolimus and sirolimus in de novo renal transplant patients: current data. Transplant. Proc. 37, 2813-2816.
102. Rice, K. M., Kinnard, R. S., Harris, R., Wright, G. L., and Blough, E. R. (2005). Effects of aging on pressure-induced MAPK activation in the rat aorta. Pflugers Arch. 450, 192-199.
103. Ruderman, N. B., Xu, X. J., Nelson, L., Cacicedo, J. M., Saha, A. K., Lan, E, and Ido, Y. (2010). AMPK and SIRT1: a long-standing partnership? Am. J. Physiol. Endocrinol. Metab. 298,E751-E760.
104. Sadoshima, J., and Izumo, S. (1995). Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy. Circ. Res. 77, 1040-1052.
105. Sakuma, K., and Yamaguchi, A. (2010). Molecular mechanisms in aging and current strategies to counteract sar-copenia. Curr. Aging Sci. 3, 90-101.
106. Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., Markhard, A. L., and Sabatini, D. M. (2006). Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22,159-168.
107. Sarbassov, D. D., Guertin, D. A., Ali, S. M., and Sabatini, D. M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307,1098-1101.
108. Schachinger, V., Britten, M. B., and Zei-her, A. M. (2000). Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101, 1899-1906.
109. Selman, C., Lingard, S., Choudhury, A. I., Batterham, R. L., Claret, M., Clements, M., Ramadani, F., Okken-haug, K., Schuster, E., Blanc, E., Piper, M. D., Al-Qassab, H., Speak-man, J. R., Carmignac, D., Robinson, I. C., Thornton, J. M., Gems, D., Partridge, L., and Withers, D. J. (2008). Evidence for lifespan extension and delayed age-related bio-markers in insulin receptor substrate 1 null mice. FASEB J. 22, 807-818.
110. Selman, C., Tullet, J. M., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, M., Al-Qassab, H., Carmignac, D., Ramadani, F., Woods, A., Robinson, I. C., Schuster, E., Batterham, R. L., Kozma, S. C, Thomas, G., Carling, D., Okken-haug, K., Thornton, J. M., Partridge, L., Gems, D., and Withers, D. J. (2009). Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326, 140-144.
111. Sengupta, S., Peterson, T. R., and Sabatini, D. M. (2010). Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol. Cell 40,310-322.
112. Sesso, H. D., Buring, J. E., Christen, W. G., Kurth, T., Belanger, C., Mac-Fadyen, J., Bubes, V., Manson, J. E., Glynn, R. J., and Gaziano, J. M. (2008). Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 300,2123-2133.
113. Shackelford, D. B., and Shaw, R. J. (2009). The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat. Rev. Cancer 9, 563-575.
114. Shih, H., Lee, B., Lee, R. J., and Boyle, A. J. (2011). The aging heart and post-infarction left ventricular remodeling. J. Am. Coll. Cardiol. 57, 9-17.
115. Shinmura, K., Tamaki, K., Sano, M., Murata, M., Yamakawa, H., Ishida, H., and Fukuda, K. (2011). Impact of longterm caloric restriction on cardiac senescence: caloric restriction ameliorates cardiac diastolic dysfunction associated with aging. J. Mol. Cell. Cardiol. 50, 117-127.
116. Smoliga, J. M., Baur, J. A., and Hausen-blas, H. A. (2011). Resveratrol and health - a comprehensive review of human clinical trials. Mol. Nutr. Food Res. 0.55, 1129-1141.
117. Soesanto, W., Lin, H. Y., Hu, E., Lefler, S., Litwin, S. E., Sena, S., Abel, E.D., Symons, J. D., and Jalili, T. (2009). Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in sponta neously hypertensive rats. Hyperten sion 54, 1321-1327.
118. Stallone, G., Schena, A., Infante, B., Di, P. S., Loverre, A., Maggio, G., Ranieri, E., Gesualdo, L., Schena, F.P., and Grandaliano, G. (2005). Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N. Engl. J. Med. 352, 1317-1323.
119. Stanfel, M. N., Shamieh, L. S., Kae-berlein, M., and Kennedy, B. K. (2009). The TOR pathway comes of age. Biochim. Biophys. Acta 1790, 1067-1074.
120. Stockklauser-Farber, K., Ballhausen, T., Laufer, A., and Rosen, P. (2000). Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochim. Biophys. Acta 1535, 10-20.
121. Sung, M. M., Koonen, D. P., Soltys, C. L., Jacobs, R. L., Febbraio, M., and Dyck, J. R. (2011). Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction. J. Mol. Med. 89, 459-469.
122. Sydow, K., and Munzel, T. (2003). ADMA and oxidative stress. Atheroscler. Suppl. 4, 41-51.
123. Tanabe, T., Maeda, S., Miyauchi, T., Iemitsu, M., Takanashi, M., Irukayama-Tomobe, Y., Yokota, T., Ohmori, H., and Matsuda, M. (2003). Exercise training improves ageing-induced decrease in eNOS expression of the aorta. Acta Physiol. Scand. 178,3-10.
124. Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Wei-jer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Ker-sten, S., Moonen-Kornips, E., Hes-selink, M. K. C., Kunz, I., Schrauwen-Hinderling, V. B., Blaak, E. E., Auwer, J., and Schrauwen, P. (2011). Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 14 612-622
125. Tu, V. C., Bahl, J. J., and Chen, Q. M. (2002). Signals of oxidant-induced cardiomyocyte hypertrophy: key activation of p70 S6 kinase-1 and phosphoinositide 3-kinase. J. Pharmacol. Exp. Ther. 300, 1101-1110.
126. Tutar, E., Ozcan, M., Kilickap, M., Gulec, S., Aras, O., Pamir, G., Oral, D., Dan-delet, L., and Key, N. S. (2003). Elevated whole-blood tissue factor pro-coagulant activity as a marker of restenosis after percutaneous trans-luminal coronary angioplasty and stent implantation. Circulation 108, 1581-1584.
127. Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C, Auwerx, J., and Thomas, G. (2004). Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200-205.
128. Ungvari, Z., Kaley, G., de, C. R, Son-ntag, W. E., and Csiszar, A. (2010). Mechanisms of vascular aging: new perspectives. J. Gerontol. A Biol. Sci. Med. Sci. 65, 1028-1041.
129. van der Loo, B., Labugger, R., Skep-per, J. N., Bachschmid, M., Kilo, J., Powell, J. M., Palacios-Callender, M., Erusalimsky, J. D., Quaschning, T., Malinski, T., Gygi, D., Ullrich, V., and Luscher, T. F. (2000). Enhanced peroxynitrite formation is associated with vascular aging. J. Exp. Med. 192, 1731-1744.
130. Vanhoutte, P. M., Shimokawa, H., Tang, E. H., and Feletou, M. (2009). Endothelial dysfunction and vascular disease. Acta Physiol. (Oxf.) 196, 193-222.
131. Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C., Martin, H.,Zei-her, A. M., and Dimmeler, S. (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89, E1-E7.
132. Vivekananthan, D. P., Penn, M. S., Sapp, S. K.,Hsu, A.,andTopol,E. J. (2003). Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361, 2017-2023.
133. Waksman, R., Pakala, R., Burnett, M. S., Gulick, C. P., Leborgne, L., Fournad-jiev, J., Wolfram, R., and Hellinga, D. (2003). Oral rapamycin inhibits growth of atherosclerotic plaque in apoE knock-out mice. Cardiovasc. Radiat. Med. 4, 34-38.
134. Wang, Y., Liang, Y., and Vanhoutte, P. M. (2011). SIRT1 and AMPK in regulating mammalian senescence: a critical review and a working model. FEBS Lett. 585, 986-994.
135. Wei, L. (2004). Lysophospholipid signaling in cardiac myocyte hypertrophy. J. Mol. Cell. Cardiol. 36, 465-468.
136. Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., Bohm, M., and Nickenig, G. (2005). Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353, 999-1007.
137. Willcox, B. J., Willcox, D. C., Todoriki, H., Fujiyoshi, A., Yano, K., He, Q., Curb, J. D., and Suzuki, M. (2007). Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world's longest-lived people and its potential impact on morbidity and life span. Ann. N. Y. Acad. Sci. 1114,434-455.
138. Yang, Z., and Ming, X. F. (2006). Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin. Med. Res. 4, 53-65.
139. Zang, M., Xu, S., Maitland-Toolan, K. A., Zuccollo, A., Hou, X., Jiang, B., Wierzbicki, M., Verbeuren, T. J., and Cohen, R. A. (2006). Polyphe-nols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55, 2180-2191.
140. Zhang, J. (2006). Resveratrol inhibits insulin responses in a SirT1-independent pathway. Biochem. J. 397,519-527.
141. Zhang, P., Hu, X., Xu, X., Fassett, J., Zhu, G., Viollet, B., Xu, W., Wiczer, B., Bernlohr, D. A., Bache, R. J., and Chen,Y. (2008). AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice. Hypertension 52, 918-924.
142. Zhou, X., Perez, F., Han, K., and Jurivich, D. A. (2006). Clonal senescence alters endothelial ICAM-1 function. Mech. Ageing Dev. 127, 779-785.
143. Zmonarski, S. C., Boratynska, M., Rabczynski, J., Kazimierczak, K., and Klinger, M. (2005). Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment. Transplant. Proc. 37, 964-966.
144. Zoncu, R., Efeyan, A., and Sabatini, D. M. (2011). mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12,21-35.
145. Zu, Y., Liu, L., Lee, M. Y., Xu, C., Liang, Y., Man, R. Y., Vanhoutte, P. M., and Wang, Y. (2010). SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ. Res. 106, 1384-1393.